4.36
Aligos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
FY22:
13.9
FY23:
15.5
FY24:
3.95
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−128
FY22:
−97.6
FY23:
−88.1
FY24:
−89.2
FY25:
−88.0
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−145
(positive)
Change from FY21 to FY25
millions USD
FY21:
−128
FY22:
−95.9
FY23:
−86.9
FY24:
−131
FY25:
−23.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−128
FY22:
−96.0
FY23:
−87.7
FY24:
−131
FY25:
−24.2
All amounts in millions USD